Industry News

Dec 19, 2013
By BioPharm International Editors
Merck and GlaxoSmithKline begin clinical trial of pazopanib for the treatment of advanced renal-cell carcinoma.
Dec 16, 2013
By BioPharm International Editors
Almost 400 new medicines for infectious diseases, including viral infections, bacterial infections, fungal infections and parasitic infections.
Dec 12, 2013
By BioPharm International Editors
Bristol-Myers Squibb has elected Thomas Lynch, Jr., MD to its board of directors.
Dec 12, 2013
By BioPharm International Editors
GSK forms the Oncology Clinical and Translational Consortium, a scientific research network comprised of six international cancer centers.
Dec 12, 2013
By BioPharm International Editors
Octapharma and Pfizer form an agreement for the future marketing and commercialization of human prothrombin complex concentrate.
Dec 12, 2013
By BioPharm International Editors
BioWa and Lonza have entered into a licensing agreement with MedImmune for cell line technology.
Dec 12, 2013
By BioPharm International Editors
Johnson&Johnson will open a network of partnering offices across the UK.
Dec 04, 2013
By BioPharm International Editors
LSNE appoints Shawn Cain as COO, a new position within the company.
Dec 03, 2013
By BioPharm International Editors
TxCell has received manufacturing accreditation status of its cell-therapy production site in Besancon, France, from the French National Agency for Drug Safety (ANSM).
Dec 02, 2013
By BioPharm International Editors
SGS Life Science Services announced that its bioanalytical laboratory in Poitiers, France has received GMP certification, following approval from ANSM.
native1_300x100
lorem ipsum